Ultraviolet radiation has previously been associated with conjunctivochalasis [ 7].
The protective effect of TGF-β3 against large doses of radiation has previously been seen by Potten et al. (1997) and Booth et al. (2000) as a four to six-fold increase in intestinal crypt survival in mice irradiated with doses between 8 and 16 Gy of 300 keV x-rays to the abdomen.
Radiation oncologists have previously treated all neck node levels in NPC comprehensively with definitive intent radiotherapy or prophylactic irradiation [ 20].
Together, these data demonstrate that both UV radiation and cisplatin, which have previously been shown to promote the degradation of CtBP proteins in other experimental models, also do so in the MCF-7 breast cancer cell line.
This was unexpected, since we have previously demonstrated radiation-induced up-regulation in vitro (by qRT-PCR), and an in vivo study demonstrated increased concentration of radiolabeled octreotide after priming but without a direct proof of SSTR up-regulation [10 13].
We have previously described radiation-induced immunogenic modulation of tumour cells (Chakraborty et al, 2003, 2004; Garnett et al, 2004; Reits et al, 2006).
We have previously reported increased radiation-induced intestinal epithelial cell apoptosis and epithelial barrier dysfunction in response to LPS challenge that resulted in translocation of commensal bacteria in GC-C−/− mice [ 16, 17].
Other scientists have previously suggested that neutron radiation may have been responsible for the ghostly image of a crucified man with his arms crossed, although no plausible explanation has been offered for the source of the radiation.
We have previously shown that YM155 sensitises tumour cells to radiation by inhibiting the repair of radiation-induced DNA damage.
I have previously discussed general safety issues about ionizing radiation as it applies to imaging studies (e.g., CT, X-ray, etc)., but thought I would get a little more specific.
